Skip to main content

Dismal Data: GDP & infra growth rates slow, budget gap widens

To keep you updated, we send Daily Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here
The Economic Times

Daily Newsletter

Subscribe to ET Prime

Wed, Nov 30, 2022 | 07:51 PM IST

GUJARAT HIMACHAL
#NRI Special#EV Calculator#EconomyTracker#Whatsbuzzing
Top stories of the day
India's Q2 economic growth slows to 6.3% amid rising policy rates India's Q2 economic growth slows to 6.3% amid rising policy rates
The gross domestic product (GDP) reading for the three months ended September 30 slowed from robust growth of 13.5 pe...
Core sector growth slows down to 0.1% in Oct
A Tata deal could help India score against China
India's Apr-Oct budget gap widens as spendings rise
How SEBI's new rule will make debt MFs less risky
FII buying, China lift Sensex to 63K for the first time ever
Air India-Vistara deal: Inside Tata's aviation reboot
Govt has a budget plan to counter global slowdown
NIFTY at new high: What do critical numbers indicate?
ELECTION WITH ET All News »
NRI reckoner
Canada is working on plans to boost immigration among French speakers
Nova Scotia is about to launch its new 'francophone' immigration action plan, to accelerate application process of speakers and learners of the French language. The plan, 'Growing Nova Scotia's Francophone Population: An Action Plan for Success (2022-25)' aims to attract French-speaking immigrants to support the existing francophone and Acadian communities.​​

Top Gainers

NSE
4 companies (largecap) appreciated more than 5%
Varun Beverages 9.04%
Go Fashion 8.42%
More from Gainers

Top Losers

NSE
4 companies (largecap) price decreased more than -3%
New India Assurance -5.00%
Vivo Collaboration Solutions Ltd. -4.95%
More from Losers

Experience your trusted ET newspaper. Now in a brand new way.
The Economic Times print edition. Experience it now with your ET Prime membership.

Read Today's Print Edition
More From our Partners
Meet the Drapers Season 5 comes to an end, time to apply for season 6
To make the world a better place and have ideas that can solve global challenges, don't sit around, apply for the next season of 'Meet the Drapers' and make your big ideas a reality.
Vistara-Air India merger: Singapore Airlines' India runway promises both profit and potholes Vistara-Air India merger: Singapore Airlines' India runway promises both profit and potholes
Covid has underscored the danger of relying too heavily on a single market. A multi-hub strategy, in which airlines o...
New market high: What the numbers indicate to us
Will you benefit by opting for higher pension from EPS?
Prannoy, Radhika Roy resign from NDTV board
Adani wins Dharavi redevelopment rights
Toyota Kirloskar VC Vikram Kirloskar no more
Discoms' outstanding dues dip by Rs 24,689 cr
Top cos should invest more: Uday Kotak
Govt targets to cross 1 cr job-mark in 2 yrs
Germany to loosen rules for skilled workers
Strong NBFCs may boost AUM by 12-13%
These are the best & worst cities for expats
Want to study abroad? First calculate ROI
More From our Partners
The fuss-free checklist for millennials and 40-plus professionals who want to get savvy with retirement planning

Separating facts from myths and presenting information that counts, here's all that you need to know about why you need a retirement corpus, from how to calculate one to how to protect one. Whether you are a millennial or a professional in their 40s, here's how you can factor in some of the broader goals and assess some of the personal parameters to devise a solid retirement plan for yourself.

Follow Us on ET:
Facebook Twitter YouTube LinkedIn
About us|Advertise with us|Feedback|Sitemap|Code of Ethics
© 2022 Times Internet Limited.
To ensure delivery directly to your inbox, please add newsletter@economictimesnews.com to your address book today.
If you are having trouble viewing this newsletter, please click here
To unsubscribe or edit your subscriptions please click here

Comments

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr

Israel activates evacuation plan for 28 communities along Lebanon border

To keep you updated, we send Defence News to your mailbox. In case, you wish to Unsubscribe Click Here Defence News Dear Reader, Just catching up? Here are the top